Holdings

Redmile Group, LLC

As of Sep 30, 2026, Redmile Group, LLC reported 43 positions worth US$1.35B. Largest: Nurix Therapeutics, Inc., Krystal Biotech, Inc. and Scholar Rock Holding Corporation. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Nurix Therapeutics, Inc.7.9MUS$187M+3.83MSep 30, 2026
Krystal Biotech, Inc.528KUS$175M−104KSep 30, 2026
Scholar Rock Holding Corporation3.03MUS$147M−1.28MSep 30, 2026
Stoke Therapeutics, Inc.3.87MUS$101M−76,892Sep 30, 2026
Immunome, Inc.4.36MUS$93.8M−549KSep 30, 2026
Absci Corporation6.67MUS$71.9M−68,298Sep 30, 2026
Electra Therapeutics, Inc.5.43MUS$61.1MnewSep 30, 2026
Annexon, Inc.14.3MUS$60.4M+2.41MSep 30, 2026
Neurogene Inc.1.56MUS$43.5M+150KSep 30, 2026
Regenxbio Inc.5.05MUS$38M+680KSep 30, 2026